EDGAR Filing Documents for 0001415889-22-012505

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-22-012505

Filing Date

2022-12-13

Accepted

2022-12-13 17:25:22

Documents

Period of Report

2022-12-09

Document Format Files

Seq	Description	Document	Type	Size
1		form4-12132022_051211.html	4
1		form4-12132022_051211.xml	4	7161
	Complete submission text file	0001415889-22-012505.txt		8636

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PERRYVILLE III CORPORATE PARK 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 221460521